▶ 調査レポート

ペット用医薬品の世界市場レポート2020

• 英文タイトル:Global Pet Pharmaceuticals Sales Market Report 2020

が調査・発行した産業分析レポートです。ペット用医薬品の世界市場レポート2020 / Global Pet Pharmaceuticals Sales Market Report 2020 / MRC2102QY10590資料のイメージです。• レポートコード:MRC2102QY10590
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、132ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界のペット用医薬品市場について種類別(ピル、注射、スプレー、軟膏、その他)、用途別(治療、予防)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ペット用医薬品市場の概要
・世界の主要地域別ペット用医薬品市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のペット用医薬品市場規模2015-2026:種類別(ピル、注射、スプレー、軟膏、その他)
・世界のペット用医薬品市場規模2015-2026:用途別(治療、予防)
・ペット用医薬品の米国市場規模2015-2020
・ペット用医薬品のヨーロッパ市場規模2015-2020
・ペット用医薬品の中国市場規模2015-2020
・ペット用医薬品の日本市場規模2015-2020
・ペット用医薬品の東南アジア市場規模2015-2020
・ペット用医薬品のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ペット用医薬品の製造コスト分析
・販売チャネル、流通業者、顧客
・ペット用医薬品の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Pet Pharmaceuticals Market
The global Pet Pharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Pet Pharmaceuticals Scope and Market Size
The global Pet Pharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Pet Pharmaceuticals market is segmented into
Pill
Injection
Spray
Ointment
Others

Segment by Application, the Pet Pharmaceuticals market is segmented into
Treatment
Prevention

The Pet Pharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Pet Pharmaceuticals market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Pet Pharmaceuticals Market Share Analysis
Pet Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Pharmaceuticals business, the date to enter into the Pet Pharmaceuticals market, Pet Pharmaceuticals product introduction, recent developments, etc.

The major vendors covered:
Zoetis
Merck Animal Health
Merial
Elanco
Bayer
Boehringer Ingolheim
Novartis
Virbac Group
Ceva Sante Animale
Vétoquinol S.A.

レポート目次

1 Pet Pharmaceuticals Market Overview
1.1 Pet Pharmaceuticals Product Scope
1.2 Pet Pharmaceuticals Segment by Type
1.2.1 Global Pet Pharmaceuticals Sales by Type (2020-2026)
1.2.2 Pill
1.2.3 Injection
1.2.4 Spray
1.2.5 Ointment
1.2.6 Others
1.3 Pet Pharmaceuticals Segment by Application
1.3.1 Global Pet Pharmaceuticals Sales Comparison by Application (2020-2026)
1.3.2 Treatment
1.3.3 Prevention
1.4 Pet Pharmaceuticals Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pet Pharmaceuticals Sales Growth Rate (2015-2026)
1.4.2 Global Pet Pharmaceuticals Revenue and Growth Rate (2015-2026)
1.4.3 Global Pet Pharmaceuticals Price Trends (2015-2026)

2 Pet Pharmaceuticals Estimate and Forecast by Region
2.1 Global Pet Pharmaceuticals Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pet Pharmaceuticals Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
2.2.2 Global Pet Pharmaceuticals Revenue Market Share by Region (2015-2020)
2.3 Global Pet Pharmaceuticals Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pet Pharmaceuticals Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pet Pharmaceuticals Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pet Pharmaceuticals Estimates and Projections (2015-2026)
2.4.2 Europe Pet Pharmaceuticals Estimates and Projections (2015-2026)
2.4.3 China Pet Pharmaceuticals Estimates and Projections (2015-2026)
2.4.4 Japan Pet Pharmaceuticals Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pet Pharmaceuticals Estimates and Projections (2015-2026)
2.4.6 India Pet Pharmaceuticals Estimates and Projections (2015-2026)
3 Global Pet Pharmaceuticals Competition Landscape by Players
3.1 Global Top Pet Pharmaceuticals Players by Sales (2015-2020)
3.2 Global Top Pet Pharmaceuticals Players by Revenue (2015-2020)
3.3 Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Pharmaceuticals as of 2019)
3.4 Global Pet Pharmaceuticals Average Price by Company (2015-2020)
3.5 Manufacturers Pet Pharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pet Pharmaceuticals Players (Opinion Leaders)
4 Global Pet Pharmaceuticals Market Size by Type
4.1 Global Pet Pharmaceuticals Historic Market Review by Type (2015-2020)
4.1.1 Global Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
4.1.2 Global Pet Pharmaceuticals Revenue Market Share by Type (2015-2020)
4.1.3 Global Pet Pharmaceuticals Price by Type (2015-2020)
4.2 Global Pet Pharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pet Pharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Pharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Global Pet Pharmaceuticals Price Forecast by Type (2021-2026)
5 Global Pet Pharmaceuticals Market Size by Application
5.1 Global Pet Pharmaceuticals Historic Market Review by Application (2015-2020)
5.1.1 Global Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
5.1.2 Global Pet Pharmaceuticals Revenue Market Share by Application (2015-2020)
5.1.3 Global Pet Pharmaceuticals Price by Application (2015-2020)
5.2 Global Pet Pharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pet Pharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Pharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Pharmaceuticals Price Forecast by Application (2021-2026)

6 United States Pet Pharmaceuticals Market Facts & Figures
6.1 United States Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
6.2 United States Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
6.3 United States Pet Pharmaceuticals Sales Market Share by Application (2015-2020)

7 Europe Pet Pharmaceuticals Market Facts & Figures
7.1 Europe Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
7.2 Europe Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
7.3 Europe Pet Pharmaceuticals Sales Market Share by Application (2015-2020)

8 China Pet Pharmaceuticals Market Facts & Figures
8.1 China Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
8.2 China Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
8.3 China Pet Pharmaceuticals Sales Market Share by Application (2015-2020)

9 Japan Pet Pharmaceuticals Market Facts & Figures
9.1 Japan Pet Pharmaceuticals Sales Market Share by Company (3015-3030)
9.2 Japan Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
9.3 Japan Pet Pharmaceuticals Sales Market Share by Application (2015-2020)

10 Southeast Asia Pet Pharmaceuticals Market Facts & Figures
10.1 Southeast Asia Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Pet Pharmaceuticals Sales Market Share by Application (2015-2020)

11 India Pet Pharmaceuticals Market Facts & Figures
11.1 India Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
11.2 India Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
11.3 India Pet Pharmaceuticals Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Pet Pharmaceuticals Business
12.1 Zoetis
12.1.1 Zoetis Corporation Information
12.1.2 Zoetis Business Overview
12.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Zoetis Pet Pharmaceuticals Products Offered
12.1.5 Zoetis Recent Development
12.2 Merck Animal Health
12.2.1 Merck Animal Health Corporation Information
12.2.2 Merck Animal Health Business Overview
12.2.3 Merck Animal Health Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Animal Health Pet Pharmaceuticals Products Offered
12.2.5 Merck Animal Health Recent Development
12.3 Merial
12.3.1 Merial Corporation Information
12.3.2 Merial Business Overview
12.3.3 Merial Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merial Pet Pharmaceuticals Products Offered
12.3.5 Merial Recent Development
12.4 Elanco
12.4.1 Elanco Corporation Information
12.4.2 Elanco Business Overview
12.4.3 Elanco Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Elanco Pet Pharmaceuticals Products Offered
12.4.5 Elanco Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bayer Pet Pharmaceuticals Products Offered
12.5.5 Bayer Recent Development
12.6 Boehringer Ingolheim
12.6.1 Boehringer Ingolheim Corporation Information
12.6.2 Boehringer Ingolheim Business Overview
12.6.3 Boehringer Ingolheim Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer Ingolheim Pet Pharmaceuticals Products Offered
12.6.5 Boehringer Ingolheim Recent Development
12.7 Novartis
12.7.1 Novartis Corporation Information
12.7.2 Novartis Business Overview
12.7.3 Novartis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Pet Pharmaceuticals Products Offered
12.7.5 Novartis Recent Development
12.8 Virbac Group
12.8.1 Virbac Group Corporation Information
12.8.2 Virbac Group Business Overview
12.8.3 Virbac Group Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Virbac Group Pet Pharmaceuticals Products Offered
12.8.5 Virbac Group Recent Development
12.9 Ceva Sante Animale
12.9.1 Ceva Sante Animale Corporation Information
12.9.2 Ceva Sante Animale Business Overview
12.9.3 Ceva Sante Animale Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ceva Sante Animale Pet Pharmaceuticals Products Offered
12.9.5 Ceva Sante Animale Recent Development
12.10 Vétoquinol S.A.
12.10.1 Vétoquinol S.A. Corporation Information
12.10.2 Vétoquinol S.A. Business Overview
12.10.3 Vétoquinol S.A. Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Vétoquinol S.A. Pet Pharmaceuticals Products Offered
12.10.5 Vétoquinol S.A. Recent Development

13 Pet Pharmaceuticals Manufacturing Cost Analysis
13.1 Pet Pharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pet Pharmaceuticals
13.4 Pet Pharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pet Pharmaceuticals Distributors List
14.3 Pet Pharmaceuticals Customers

15 Market Dynamics
15.1 Pet Pharmaceuticals Market Trends
15.2 Pet Pharmaceuticals Opportunities and Drivers
15.3 Pet Pharmaceuticals Market Challenges
15.4 Pet Pharmaceuticals Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Pet Pharmaceuticals Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Pet Pharmaceuticals Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Pet Pharmaceuticals Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pet Pharmaceuticals Sales (K MT) by Region (2015-2020)
Table 5. Global Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 6. Global Pet Pharmaceuticals Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pet Pharmaceuticals Revenue Share by Region (2015-2020)
Table 8. Global Pet Pharmaceuticals Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Pet Pharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pet Pharmaceuticals Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pet Pharmaceuticals Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pet Pharmaceuticals (K MT) of Key Companies (2015-2020)
Table 13. Global Pet Pharmaceuticals Sales Share by Company (2015-2020)
Table 14. Global Pet Pharmaceuticals Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pet Pharmaceuticals Revenue Share by Company (2015-2020)
Table 16. Global Pet Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Pharmaceuticals as of 2019)
Table 17. Global Pet Pharmaceuticals Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Pet Pharmaceuticals Manufacturing Sites and Area Served
Table 19. Manufacturers Pet Pharmaceuticals Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pet Pharmaceuticals Players
Table 22. Global Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 23. Global Pet Pharmaceuticals Sales Share by Type (2015-2020)
Table 24. Global Pet Pharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pet Pharmaceuticals Price (K MT) by Type (2015-2020)
Table 26. Global Pet Pharmaceuticals Sales Share by Type (2021-2026)
Table 27. Global Pet Pharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pet Pharmaceuticals Revenue Share by Type (2021-2026)
Table 29. Global Pet Pharmaceuticals Price (K MT) by Type (2021-2026)
Table 30. Global Pet Pharmaceuticals Sales (K MT) by Application (2015-2020)
Table 31. Global Pet Pharmaceuticals Sales Share by Application (2015-2020)
Table 32. Global Pet Pharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pet Pharmaceuticals Price (K MT) by Application (2015-2020)
Table 34. Global Pet Pharmaceuticals Sales (K MT) by Application (2021-2026)
Table 35. Global Pet Pharmaceuticals Sales Share by Application (2021-2026)
Table 36. Global Pet Pharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pet Pharmaceuticals Revenue Share by Application (2021-2026)
Table 38. Global Pet Pharmaceuticals Price (K MT) by Application (2021-2026)
Table 39. United States Pet Pharmaceuticals Sales (K MT) by Company (2015-2020)
Table 40. United States Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
Table 41. United States Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 42. United States Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 43. United States Pet Pharmaceuticals Sales (K MT) by Application (2015-2020)
Table 44. United States Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 45. Europe Pet Pharmaceuticals Sales (K MT) by Company (2015-2020)
Table 46. Europe Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
Table 47. Europe Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 48. Europe Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 49. Europe Pet Pharmaceuticals Sales (K MT) by Application (2015-2020)
Table 50. Europe Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 51. China Pet Pharmaceuticals Sales (K MT) by Company (2015-2020)
Table 52. China Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
Table 53. China Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 54. China Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 55. China Pet Pharmaceuticals Sales (K MT) by Application (2015-2020)
Table 56. China Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 57. Japan Pet Pharmaceuticals Sales (K MT) by Company (2015-2020)
Table 58. Japan Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
Table 59. Japan Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 60. Japan Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 61. Japan Pet Pharmaceuticals Sales (K MT) by Application (2015-2020)
Table 62. Japan Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pet Pharmaceuticals Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 69. India Pet Pharmaceuticals Sales (K MT) by Company (2015-2020)
Table 70. India Pet Pharmaceuticals Sales Market Share by Company (2015-2020)
Table 71. India Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 72. India Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 73. India Pet Pharmaceuticals Sales (K MT) by Application (2015-2020)
Table 74. India Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Zoetis Pet Pharmaceuticals Product
Table 79. Zoetis Recent Development
Table 80. Merck Animal Health Corporation Information
Table 81. Merck Animal Health Description and Business Overview
Table 82. Merck Animal Health Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Merck Animal Health Pet Pharmaceuticals Product
Table 84. Merck Animal Health Recent Development
Table 85. Merial Corporation Information
Table 86. Merial Description and Business Overview
Table 87. Merial Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Merial Pet Pharmaceuticals Product
Table 89. Merial Recent Development
Table 90. Elanco Corporation Information
Table 91. Elanco Description and Business Overview
Table 92. Elanco Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Elanco Pet Pharmaceuticals Product
Table 94. Elanco Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Bayer Pet Pharmaceuticals Product
Table 99. Bayer Recent Development
Table 100. Boehringer Ingolheim Corporation Information
Table 101. Boehringer Ingolheim Description and Business Overview
Table 102. Boehringer Ingolheim Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Boehringer Ingolheim Pet Pharmaceuticals Product
Table 104. Boehringer Ingolheim Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Novartis Pet Pharmaceuticals Product
Table 109. Novartis Recent Development
Table 110. Virbac Group Corporation Information
Table 111. Virbac Group Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Virbac Group Description and Business Overview
Table 113. Virbac Group Pet Pharmaceuticals Product
Table 114. Virbac Group Recent Development
Table 115. Ceva Sante Animale Corporation Information
Table 116. Ceva Sante Animale Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Ceva Sante Animale Description and Business Overview
Table 118. Ceva Sante Animale Pet Pharmaceuticals Product
Table 119. Ceva Sante Animale Recent Development
Table 120. Vétoquinol S.A. Corporation Information
Table 121. Vétoquinol S.A. Description and Business Overview
Table 122. Vétoquinol S.A. Pet Pharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Vétoquinol S.A. Pet Pharmaceuticals Product
Table 124. Vétoquinol S.A. Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Pet Pharmaceuticals Distributors List
Table 128. Pet Pharmaceuticals Customers List
Table 129. Pet Pharmaceuticals Market Key Trends
Table 130. Pet Pharmaceuticals Key Opportunities and Drivers
Table 131. Pet Pharmaceuticals Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Pharmaceuticals Product Picture
Figure 2. Global Pet Pharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pet Pharmaceuticals Market Share by Application in 2020 & 2026
Figure 6. Treatment Examples
Figure 7. Prevention Examples
Figure 8. Global Pet Pharmaceuticals Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Pet Pharmaceuticals Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Pet Pharmaceuticals Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Pet Pharmaceuticals Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Pet Pharmaceuticals Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Pet Pharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Pet Pharmaceuticals Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Pet Pharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Pet Pharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Pet Pharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Pet Pharmaceuticals Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Pet Pharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Pet Pharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Pet Pharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pet Pharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Pet Pharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Pet Pharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Pet Pharmaceuticals Players Market Share by Revenue in Pet Pharmaceuticals 2015 & 2019
Figure 26. Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Pet Pharmaceuticals Revenue Share by Type (2015-2020)
Figure 28. Global Pet Pharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Pet Pharmaceuticals Revenue Share by Application (2015-2020)
Figure 30. Global Pet Pharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 32. United States Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 33. Europe Pet Pharmaceuticals Sales Market Share by Company in 2019
Figure 34. Europe Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 35. Europe Pet Pharmaceuticals Sales Market Share by Application in 2019
Figure 36. China Pet Pharmaceuticals Sales Market Share by Company in 2019
Figure 37. China Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 38. China Pet Pharmaceuticals Sales Market Share by Application in 2019
Figure 39. Japan Pet Pharmaceuticals Sales Market Share by Company in 2019
Figure 40. Japan Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 41. Japan Pet Pharmaceuticals Sales Market Share by Application in 2019
Figure 42. Southeast Asia Pet Pharmaceuticals Sales Market Share by Company in 2019
Figure 43. Southeast Asia Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 44. Southeast Asia Pet Pharmaceuticals Sales Market Share by Application in 2019
Figure 45. India Pet Pharmaceuticals Sales Market Share by Company in 2019
Figure 46. India Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 47. India Pet Pharmaceuticals Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Pet Pharmaceuticals
Figure 50. Manufacturing Process Analysis of Pet Pharmaceuticals
Figure 51. Pet Pharmaceuticals Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed